Asia-Pacific In-vitro Fertilization Services Market to Reach $7.1 Bn, by 2022
The Asia-Pacific IVF cycle market is characterized by improvement in standards of living, increasing number of couples delaying parenthood due to professional commitments, and trends towards financial stability.
Get sample copy of this report: https://www.alliedmarketresearch.com/request-sample/853.
The Asia-Pacific IVF cycle market is characterized by improvement in standards of living, increasing number of couples delaying parenthood due to professional commitments, and trends towards financial stability.
Get sample copy of this report: https://www.alliedmarketresearch.com/request-sample/853.
Asia-Pacific In-Vitro Fertilization (IVF) Services Market– Introduction The Asia-Pacific In-vitro Fertilization Market is expected to reach $7 billion by 2022, growing at a CAGR of 13.3% from 2016 to 2022. The fresh cycle (non-donor) segment accounted for approximately three-fourths share in 2015 and is expected to maintain its dominance during the forecast period. The rapidly growing geriatric population has been a major concern for the government in most of the countries in the Asia-Pacific region. Several countries, such as Vietnam, Cambodia, and Philippines, have fertility rates of 2 births per woman, which is below the average rate of 2.1 births per woman. These countries are keen on boosting their fertility rates to maintain balance between new born and geriatric populations. Indonesia in particular had a fertility rate of 2.1 and geriatric population of about 5% of the total population in 2015. According to AgeingAsia.org, this number is anticipated to reach 74 million by 2050. Korea, which had a fertility rate of 1.25 in 2014, has announced financial support for infertility treatment. Similarly, Singapore, with fertility rate of 0.80 in 2014, has increased the subsidy for treatment to 75% of the treatment cost. These factors have been instrumental in driving the growth of the Asia-Pacific IVF cycle market.
Introduction Scope of the Report Key Benefits Key Audiences
- Page 1: Asia-Pacific In-vitro Fertilization
- Page 5 and 6: Table ofContents: 1. Introduction 2
- Page 7 and 8: Asia-Pacific In-Vitro Fertilization
- Page 9 and 10: Asia-Pacific In-Vitro Fertilization
<strong>In</strong>troduction<br />
Scope of<br />
the Report<br />
Key Benefits<br />
Key Audiences
Change language